Want to see KR:006280 full AI Analyst Report?
GC Biopharma Corp. (006280) Financial Statements
GC Biopharma Corp. Financial Overview
GC Biopharma Corp.'s market cap is currently $1.49T. The company's EPS TTM is $-4372.16; its P/E ratio is -29.78; and it has a dividend yield of 1.15%. GC Biopharma Corp. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.99T | $ 1.68T | $ 1.63T | $ 1.71T | $ 1.54T |
| Gross Profit | $ 536.00B | $ 481.93B | $ 484.63B | $ 581.80B | $ 520.59B |
| Operating Income | $ 67.81B | $ 32.11B | $ 34.44B | $ 81.26B | $ 73.66B |
| EBITDA | $ 155.46B | $ 80.36B | $ 109.81B | $ 187.32B | $ 159.43B |
| Net Income | $ -4.67B | $ -26.28B | $ -26.63B | $ 65.45B | $ 123.21B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 50.80B | $ 24.00B | $ 55.51B | $ 112.31B | $ 202.94B |
| Total Assets | $ 2.97T | $ 2.74T | $ 2.64T | $ 2.53T | $ 2.46T |
| Total Debt | $ 982.14B | $ 828.14B | $ 724.02B | $ 575.54B | $ 606.57B |
| Net Debt | $ 932.77B | $ 805.58B | $ 674.32B | $ 470.18B | $ 420.51B |
| Total Liabilities | $ 1.58T | $ 1.26T | $ 1.10T | $ 958.90B | $ 962.39B |
| Stockholders' Equity | $ 1.22T | $ 1.25T | $ 1.30T | $ 1.33T | $ 1.27T |
| Cash Flow | |||||
| Free Cash Flow | $ 27.10B | $ -95.85B | $ -131.46B | $ 24.46B | $ 2.44B |
| Operating Cash Flow | $ 99.46B | $ -53.46B | $ -5.47B | $ 119.15B | $ 125.98B |
| Investing Cash Flow | $ -186.65B | $ -67.89B | $ -150.24B | $ -205.26B | $ -132.08B |
| Financing Cash Flow | $ 111.44B | $ 93.85B | $ 100.51B | $ -2.48B | $ -41.27B |
Currency in KRW